Because loss of AMPK-α1 was T cell specific, we can be certain that this was a cell-autonomous effect, unlike a previous study (Faubert et al., 2013) that used a B cell lymphoma model. This evidence concerns the gene PRKAA1 and B-cell non-Hodgkin lymphoma.